Do We Need Arguments Concerning What is Better, Sartans or ACE Inhibitors? (Part 1)

A.D. Radchenko

Abstract

This article is the first part of the review of the literature data on the mechanism of action and efficacy of angiotensin receptor blockers II (ARBs) in reducing blood pressure and preventing end-organ damage. A comparison with the action of angiotensin-converting enzyme (ACE) inhibitors is being carried out. The authors concluded that the significant difference, that would have clinical significance between ARBs and ACE inhibitors, hasn’t been found.

Full Text:

References

2013 ESH/ESC Guidelines for the management of arterial hypertension TheTask Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC) // Journal of Hypertension. — 2013. — Vol. 31. — P. 1281-1357.